|
A study information animation to help support the informed consent of potential participants considering participation in the Velodrome (WR42221) clinical trial.
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No Language (In English)
Russian
|
|
A study information animation to help support the informed consent of potential participants considering participation in the Velodrome (WR42221) clinical trial.
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No Language (In English)
Hebrew
|
|
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised double-masked, phase 3,…
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked,…
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
Change Makers Campaign video
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No
|
|
Canada Ophthalmology Team Introduction 2022
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No Language (In English)
English, French
|
|
Test
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No Language (In English)
Chinese, English
|
|
在正常的血管中Ang-1會透過與Tie2…
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No Language (In English)
English
|
|
A study information animation to help support the informed consent of potential participants considering participation in the Velodrome (WR42221) clinical trial.
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No Language (In English)
German (Germany)
|
|
A study information animation to help support the informed consent of potential participants considering participation in the Velodrome (WR42221) clinical trial.
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No Language (In English)
Korean
|
|
A study information animation to help support the informed consent of potential participants considering participation in the Velodrome (WR42221) clinical trial.
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No Language (In English)
German (Switzerland)
|
|
A study information animation to help support the informed consent of potential participants considering participation in the Velodrome (WR42221) clinical trial.
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No Language (In English)
French (Belgium)
|
|
A study information animation to help support the informed consent of potential participants considering participation in the Velodrome (WR42221) clinical trial.
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No Language (In English)
Dutch
|
|
A study information animation to help support the informed consent of potential participants considering participation in the Velodrome (WR42221) clinical trial.
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No Language (In English)
Portuguese (Brazil)
|
|
A study information animation to help support the informed consent of potential participants considering participation in the Velodrome (WR42221) clinical trial.
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No Language (In English)
English
|
|
A study information animation to help support the informed consent of potential participants considering participation in the Velodrome (WR42221) clinical trial.
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No Language (In English)
Malay (Singapore)
|